{"id":296262,"date":"2020-07-08T17:46:29","date_gmt":"2020-07-08T15:46:29","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=296262"},"modified":"2020-07-08T17:46:29","modified_gmt":"2020-07-08T15:46:29","slug":"rusko-ministarstvo-zdravlja-odobrilo-treci-preparat-protiv-virusa-korona","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2020\/07\/08\/rusko-ministarstvo-zdravlja-odobrilo-treci-preparat-protiv-virusa-korona\/","title":{"rendered":"Rusko Ministarstvo zdravlja odobrilo trec\u0301i preparat protiv virusa korona"},"content":{"rendered":"<p>To je trec\u0301i odobreni preparat. Pre toga odobrenje su dobili Avifavir i Areplivir.<\/p>\n<p>Koronavir se mo\u017ee primjenjivati samo u uslovima bolni\u010dkog lije\u010denja. Preparat nije preporu\u010dljiv za trudnice i one \u017eene koji planiraju trudnoc\u0301u, tokom perioda dojenja, bubre\u017ene bolesnike, kao i za mla\u0111e od 18 godina.<\/p>\n<p>Avifavir je odobren krajem maja, a klini\u010dka ispitivanja su po\u010deta tek u aprilu.\u00a0 Areplivir je odobren po\u010detkom jula.<\/p>\n<p>Stvaranje lijeka protiv COVID-19 mo\u017ee se uporediti samo sa otkric\u0301em antibiotika koji su \u010dovje\u010danstvo spasili od bakterijskih infekcija, prenosi Sputnjik.<\/p>\n<p>Klini\u010dka istra\u017eivanja su pokazala da je njegova efikasnost 90 odsto, to jest, devet od deset osoba uz blagovremeno lije\u010denje zagarantovano nec\u0301e preminuti.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rusko Ministarstvo zdravlja odobrilo je Koronavir, preparat protiv virusa korona.<\/p>\n","protected":false},"author":1,"featured_media":296263,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-296262","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/296262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=296262"}],"version-history":[{"count":1,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/296262\/revisions"}],"predecessor-version":[{"id":296264,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/296262\/revisions\/296264"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/296263"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=296262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=296262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=296262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}